Charles E Geyer

14PUBLICATIONS
117CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Rehabilitation engineeringObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 02, 2026
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.

|Jul 17, 2026
Development and Validation of a Multimodal-Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer.

|Jun 04, 2025
Accuracy and Reproducibility of ChatGPT Responses to Breast Cancer Tumor Board Patients.

|Aug 11, 2024
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials.

Julia Foldi, Neil Carleton, Stewart J Anderson

|Jul 24, 2024
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial.

Priya Rastogi, Hanna Bandos, Peter C Lucas

|Feb 20, 2024
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.

Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi

Pageof 3

Frequent Collaborators

7 joint publications

Norman Wolmark

6 joint publications

Priya Rastogi

5 joint publications

Eleftherios P Mamounas

4 joint publications

Sandra M Swain